Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: A potential test for GH abuse in sport

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 10, 1999, Pages 3591-3601

  Wallace, Jennifer D ^a   Cuneo, Ross C ^a   Baxter, Robert ^b   Ørskov, Hans ^c   Keay, Nicola ^d   Pentecost, Claire ^d   Dall, Rolf ^c   Rosén, Thord ^e   Jørgensen, Jens Otto ^c   Cittadini, Antonio ^f   Longobardi, Salvatore ^g   Sacca, Luigi ^f   Christiansen, Jens Sandahl ^c   Bengtsson, Bengt Åke ^e   Sönksen, Peter H ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; RECOMBINANT GROWTH FACTOR; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPING; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPORTS MEDICINE;

EID: 0033305308     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.10.6037     Document Type: Article

References (75)

1. Human growth hormone: A new substance of abuse among adolescents?
2. Growth hormone and metabolism
3. The growth hormone deficiency syndrome in adults
4. Growth hormone, insulin-like growth factors and sport
5. Detection of human growth hormone doping in urine: Out of competition tests are necessary
6. Urinary growth hormone following exercise to assess growth hormone production in adults
7. Growth hormone receptor and serum binding protein: Purification, cloning and expression
8. Insulin-like growth factor binding proteins in the human circulation: A review
9. Human growth hormone replacement therapy: Pharmacological and clinical aspects
10. Body composition response to exogenous GH during training in highly conditioned adults
11. Effect of growth hormone and resistance exercise on muscle growth in young men
12. Short-term growth hormone treatment does not increase muscle protein synthesis in experienced weight lifters
13. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes
14. Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH
15. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency
16. Effect of brief exercise on circulating insulin-like growth factor I
17. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men
18. Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations
19. Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels
20. Methods for determining composition of the human body
21. A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum
22. The measurement of insulin-like growth factor I: Clinical applications and significance
23. Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline
24. Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: Relationship to fetal maturity
25. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia
26. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
27. Circulating levels and molecular distribution of the acid-labile (a) subunit of the high molecular weight insulin-like growth factor-binding protein complex in normal subjects
28. Influence of Intensive exercise on insulin-like growth factor 1, thyroid and steroid hormones in female gymnasts
29. Observations on the Soviet/Canadian transpolar ski trek: Status of selected hormones and biologically active compounds
30. Hormonal and metabolic responses of untrained, moderately trained, and highly trained men to three exercise intensities
31. Plasma growth hormone and prolactin responses to graded levels of acute exercise and to a lactate infusion
32. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults
33. Invited report of a workshop: Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency- Summary statement of the growth hormone research society workshop on adult growth hormone deficiency
34. Cholinergic and opioid involvement in release of growth hormone during exercise and recovery
35. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men
36. Diurnal variation in the elimination rate of human growth hormone (GH): The half-life of serum GH is prolonged in the evening, and affected by the source of hormone, as well as body size and serum estradiol
37. Disproportional changes in haematocrit, plasma volume, and proteins during exercise and bed rest
38. Changes in total plasma content of electrolytes and proteins with maximal exercise
39. Simulation of IGF-I pharmacokinetics after infusion of recombinant IGF-I in human subjects
40. Rapid clearance of insulin-like growth factor (IGF)-binding protein species from blood and an associated fall in circulating IGF-I following partial hepatectomy in the rat
41. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats
42. Transfer of insulin-like growth factors I and II from plasma to lymph in young goats
43. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex
44. Cellular localization and hormonal regulation of biosynthesis of insulin-like growth factor binding proteins and of the acid-labile subunit within rat liver
45. Decline of plasma growth hormone binding protein in old age
46. Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women
47. Visceral adipose tissue is associated with circulating high affinity growth hormone-binding protein
48. Androgen regulation of growth hormone binding protein
49. Growth hormone heterogeneity: Genes, isohormones, variants, and binding proteins
50. Regulation of growth hormone (GH) receptor and GH-binding protein by GH pulsatility
51. Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat
52. Regulation of human growth hormone receptor gene transcription by human growth hormone binding protein
53. Growth hormone- and prolactin-binding proteins: Soluble forms of receptors
54. Tissue distribution, turnover, and glycosylation of the long and short growth hormone receptor isoforms in rat tissues
55. Nutritional regulation of IGF-I and IGF binding proteins
56. Net fluxes over working thigh of hormones, growth factors and biomarkers of bone metabolism during short lasting dynamic exercise
57. Comparison of the effects of growth hormone and insulin-like growth factor 1 on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans
58. Physiological roles of IGF binding proteins
59. Cloning of the rat insulin-like growth factor binding protein-1 gene and analysis of its 5' promoter region
60. Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1
61. Changes in circulating insulin-like growth factor-binding protein-1 (IGFBP-1) during prolonged exercise: Effect of carbohydrate feeding
62. Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor-binding proteins-1 and -2
63. Expression of IGFBP-1 in normal and cirrhotic human livers
64. Insulin-like growth factors and their binding proteins: Biological actions
65. Insulin-like growth factor-binding protein-1: A role in glucose counterregulation?
66. Variables controlling the secretion of insulin-like growth factor binding protein-. 2 in normal human subjects
67. Different modes of growth hormone (GH) administration do not change GH binding protein activity in man
68. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
69. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: Studies in GH-deficient patients
70. Inhibitors of glucose uptake stimulate the production of insulin-like growth factor-binding protein (IGFBP-1) by human fetal liver
71. Hormonal and nutritional regulation of IGF-I and its binding proteins
72. Insulin-like growth factor I action on the rat anterior pituitary cells: Suppression of growth hormone secretion and messenger ribonucleic acid levels
73. Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3
74. Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach
75. Altered endogenous growth hormone secretory kinetics and diurnal gh-binding protein profiles in adults with chronic liver disease